Assess a range of variants for myeloid malignancies using a single assay
Learn more about the first targeted next-generation sequencing IVD test for NSCLC
Explore our uniquely broad menu of assays across all key applications.
Learn more about the Oncomine Dx Target Test – the world's first IVD NGS-based companion diagnostic test, which can deliver multiple biomarkers from one patient sample.
Trademarks | Terms and Conditions | Privacy Notices